ABT Abbott Laboratories

  1. Stocks
  2. Healthcare
  3. NYSE: ABT

Price (delayed)

$107.045

Market cap

$185.4B

P/E Ratio

39.79

Dividend/share

$2.52

EPS

$2.69

Enterprise value

$212.5B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 55

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses ...

Highlights
The gross profit has increased by 12% year-on-year and by 4.1% since the previous quarter
The revenue has grown by 10% YoY and by 3.5% from the previous quarter
Abbott Laboratories's debt has surged by 141% YoY but it has decreased by 4.4% QoQ
ABT's quick ratio is down by 24% year-on-year but it is up by 3.8% since the previous quarter
Abbott Laboratories's net income has shrunk by 66% YoY and by 13% QoQ
The EPS has plunged by 66% YoY and by 13% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.abbott.com
Peers: JNJ PFE MDT TMO

Key stats

What are the main financial stats of ABT

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
-2.05%
1 week
-5.77%
1 month
5.13%
1 year
-16.9%
YTD
-14.56%
QTD
8.31%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$48.23B
Gross profit
$27.46B
Operating income
$6.65B
Net income
$4.7B
Gross margin
56.9%
Net margin
9.7%
Abbott Laboratories's net margin has shrunk by 70% YoY and by 16% QoQ
Abbott Laboratories's net income has shrunk by 66% YoY and by 13% QoQ
Abbott Laboratories's operating margin has decreased by 22% YoY and by 13% from the previous quarter
The operating income has contracted by 14% YoY and by 10% from the previous quarter

Price vs fundamentals

How does ABT's price correlate with its fundamentals

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
ABT P/E details
P/E
39.79
P/B
3.59
P/S
3.85
EV/EBIT
28.12
EV/EBITDA
18.53
EV/Sales
4.41
The EPS has plunged by 66% YoY and by 13% from the previous quarter
ABT's P/E is 44% above its 5-year quarterly average of 28.2 and 27% above its last 4 quarters average of 32.1
ABT's price to book (P/B) is 22% lower than its 5-year quarterly average of 4.7 but 4.6% higher than its last 4 quarters average of 3.5
ABT's P/S is 15% below its 5-year quarterly average of 4.6
The revenue has grown by 10% YoY and by 3.5% from the previous quarter

Efficiency

How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has shrunk by 73% YoY and by 20% QoQ
ABT's ROE has plunged by 68% YoY and by 13% from the previous quarter
The ROIC has contracted by 35% YoY and by 16% from the previous quarter
The ROS has contracted by 20% YoY and by 12% from the previous quarter

Dividends

What is ABT's dividend history
Dividend details
DPS
$2.52
Dividend yield
2.35%
Payout ratio
93.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 91% more than the total liabilities
Abbott Laboratories's total liabilities has soared by 72% YoY
The total assets has grown by 29% YoY
Abbott Laboratories's debt is 40% lower than its equity
Abbott Laboratories's debt has surged by 141% YoY but it has decreased by 4.4% QoQ
Abbott Laboratories's debt to equity has soared by 140% YoY but it has decreased by 4.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.